Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-4-6
pubmed:abstractText
Type 2 diabetes mellitus is characterized by insulin resistance and defects in insulin secretion from pancreatic beta-cells, which have been studied by using euglycemic/hyperinsulinemic clamps. However, it is difficult to study insulin resistance and beta-cell failure by these techniques in humans. Therefore, the aim of this study was to evaluate the effect of three different antidiabetic therapeutic regimens on insulin resistance and beta-cell activity by using a mathematical model, Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1075-2765
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
194-202
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17414590-Blood Glucose, pubmed-meshheading:17414590-Diabetes Mellitus, Type 2, pubmed-meshheading:17414590-Diet, pubmed-meshheading:17414590-Drug Therapy, Combination, pubmed-meshheading:17414590-Female, pubmed-meshheading:17414590-Hemoglobin A, Glycosylated, pubmed-meshheading:17414590-Humans, pubmed-meshheading:17414590-Hyperinsulinism, pubmed-meshheading:17414590-Hypoglycemic Agents, pubmed-meshheading:17414590-Insulin, pubmed-meshheading:17414590-Insulin Resistance, pubmed-meshheading:17414590-Insulin-Secreting Cells, pubmed-meshheading:17414590-Male, pubmed-meshheading:17414590-Metformin, pubmed-meshheading:17414590-Middle Aged, pubmed-meshheading:17414590-Models, Biological, pubmed-meshheading:17414590-Motor Activity, pubmed-meshheading:17414590-Sulfonylurea Compounds
pubmed:articleTitle
Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
pubmed:affiliation
Endocrine and Metabolic Diseases Research Center Dr. Félix Gómez, University of Zulia School of Medicine, Maracaibo, Venezuela. vbermudez@hotmail.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial